EDGAR Filing Documents for 0001104659-17-073170

Form 8-K - Current report:

SEC Accession No. 0001104659-17-073170

Filing Date

2017-12-13

Accepted

2017-12-13 16:52:48

Documents

Period of Report

2017-12-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a17-27816_48k.htm	8-K	30740
2	EX-1.1	a17-27816_4ex1d1.htm	EX-1.1	233657
3	EX-5.1	a17-27816_4ex5d1.htm	EX-5.1	12886
4	EX-99.1	a17-27816_4ex99d1.htm	EX-99.1	11475
5	EX-99.2	a17-27816_4ex99d2.htm	EX-99.2	10396
6	GRAPHIC	g278164kki001.jpg	GRAPHIC	2607
	Complete submission text file	0001104659-17-073170.txt		304028

Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139

Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580

Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)